Valerie A. Laganas - Concepedia

Author

Valerie A. Laganas

AstraZeneca (United States)

Also Known As

V.A. Laganas, Valerie A. Laganas, Valerie Laganas

Publications

340

Citations

H-Index

Concepts

All Affiliations

AstraZeneca (United States)Cubist Pharmaceuticals (United States)

About

Valerie A. Laganas is an author at AstraZeneca (United States) specializing in biochemistry, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	161
2	Biochemistry	5	5	152
3	Natural Sciences	3	3	110
4	Health Sciences	2	2	42
5	Biomolecular Engineering	1	1	36

Valerie A. Laganas

Publications

325

Citations

H-Index

Page 1

	Year	Citations
In Vitro Bactericidal Activities of Daptomycin against <i>Staphylococcus aureus</i> and <i>Enterococcus faecalis</i> Are Not Mediated by Inhibition of Lipoteichoic Acid Biosynthesis Valerie A. Laganas, Jeffrey Alder, Jared Silverman Antimicrobial Agents and Chemotherapy	2003	88
Synthesis and biological activity of N-Acylated ornithine analogues of daptomycin Jason M. Hill, James M. Siedlecki, Ian B. Parr, Bioorganic & Medicinal Chemistry Letters Biological ActivityBiochemistryNatural SciencesMedicineNatural Product Biosynthesis	2003	54
Discovery of Inhibitors of 4′-Phosphopantetheine Adenylyltransferase (PPAT) To Validate PPAT as a Target for Antibacterial Therapy Boudewijn L. M. de Jonge, Grant K. Walkup, Sushmita D. Lahiri, Antimicrobial Agents and Chemotherapy Bioorganic ChemistryAntibiotic AdjuvantValidate PpatAntimicrobial ChemotherapyChemical Biology	2013	44
Array synthesis of novel lipodepsipeptide James M. Siedlecki, Jason M. Hill, Ian B. Parr, Bioorganic & Medicinal Chemistry Letters Array SynthesisLipid PreparationBiomolecular EngineeringPeptide Synthesis	2003	36
Novel Rapidly Diversifiable Antimicrobial RNA Polymerase Switch Region Inhibitors with Confirmed Mode of Action in Haemophilus influenzae Ed T. Buurman, Melinda A. Foulk, Ning Gao, Journal of Bacteriology Confirmed ModeBioorganic ChemistryEscherichia Coli S30Antimicrobial ChemotherapySquaramide Core	2012	29
The Role of a Novel Auxiliary Pocket in Bacterial Phenylalanyl-tRNA Synthetase Druggability Ayome Abibi, Andrew D. Ferguson, Paul Fleming, Journal of Biological Chemistry	2014	28
Characterization of novel respiratory syncytial virus inhibitors identified by high throughput screen Valerie A. Laganas, Ewan F. Dunn, Robert E. McLaughlin, Antiviral Research MedicineAntiviral Drug DevelopmentAntiviral TherapyVirologyAntiviral Drug	2014	21
Antimicrobial Activity of Adenine-Based Inhibitors of NAD<sup>+</sup>-Dependent DNA Ligase Ed T. Buurman, Valerie A. Laganas, Ce Feng Liu, ACS Medicinal Chemistry Letters S. PneumoniaeDrug ResistanceNucleic Acid ChemistryLiga InhibitorsInhibitory Activity	2012	13
Negishi cross-coupling enabled synthesis of novel NAD+-dependent DNA ligase inhibitors and SAR development Kerry E. Murphy-Benenato, Lakshmaiah Gingipalli, P. Ann Boriack‐Sjodin, Bioorganic & Medicinal Chemistry Letters Sar DevelopmentMedicinal ChemistryBiochemistryNatural SciencesOligonucleotide	2015	12

Page 1